About ISCT | Join ISCT | Contact Us | Media
ISCT 2019 Melbourne, Australia
  • HOME
  • Continuing Medical Education
  • Abstracts
  • Program
    • Pre-Conference Workshops
      • MSC Clinical Trial Updates
      • ISCT-CBA Cord Blood Series in Partnership with ASTCT
      • Cell Processing Track
      • Global Regulatory Perspectives Workshop
      • Trending Now
      • ISCT-FACT Cell Therapy Quality Bootcamp
    • Full Program
    • Speakers
      • Plenary Speakers
      • Full Speaker List
    • Corporate Program
    • Pre-Meeting Events (May 28)
      • Pre-Meeting GMP Facility Tours
      • Pre-Meeting Fact Accreditation Workshop
  • Photo Gallery
  • Sponsor & Exhibit

Schedule

The final ISCT 2019 program is now available! View the final program..

Wednesday
2019-05-29
Thursday
2019-05-30
Friday
2019-05-31
Saturday
2019-06-01
Wednesday
2019-05-29
08:00 - 08:30
Welcome and Regulatory Roundup (GRP Workshop)

See presentation details and speaker bios 

 

 

Welcome and Regulatory Roundup (GRP Workshop) image
Dominic Wall, PhD
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
Welcome and Regulatory Roundup (GRP Workshop) image
Dominic Wall, PhD
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
08:30 - 10:00
Quality Plans and Document Control (ISCT-FACT Quality Bootcamp)

See presentation details and speaker bios 

 

 

Quality Plans and Document Control (ISCT-FACT Quality Bootcamp) image
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
Quality Plans and Document Control (ISCT-FACT Quality Bootcamp) image
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
Quality Plans and Document Control (ISCT-FACT Quality Bootcamp) image
Guy Klamer, PhD
Quality Manager, Sydney Cord Blood Bank, Australia
Quality Plans and Document Control (ISCT-FACT Quality Bootcamp) image
Guy Klamer, PhD
Quality Manager, Sydney Cord Blood Bank, Australia
08:30 - 10:00
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop)

See presentation details and speaker bios 

 

 

Paul J. Simmons, PhD
Research & New Product Development, Mesoblast
Paul J. Simmons, PhD
Research & New Product Development, Mesoblast
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop) image
Igor Slukvin, MD, PhD
Professor, University of Wisconsin-Madison, United States
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop) image
Igor Slukvin, MD, PhD
Professor, University of Wisconsin-Madison, United States
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop) image
Robert W. Mays, PhD
VP Regenerative Medicine and Head of Neuroscience Programs, Athersys, USA
Clinical Trials Part I: MSC Sources, Applications and ‘Off the Shelf’ Products (MSC Workshop) image
Robert W. Mays, PhD
VP Regenerative Medicine and Head of Neuroscience Programs, Athersys, USA
08:30 - 10:00
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track)

See presentation details and speaker bios 

 

 

Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Sharlea Disney
CAR T -Cell Project Manager - Cell Therapies/Peter MacCallum Cancer Centre, Australia
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Sharlea Disney
CAR T -Cell Project Manager - Cell Therapies/Peter MacCallum Cancer Centre, Australia
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Wen Bo Wang, PhD
Senior Vice President, Technical Operations, Fate Therapeutics
Collection of Starting Product Before Cell Processing and Production (Cell Processing Track) image
Wen Bo Wang, PhD
Senior Vice President, Technical Operations, Fate Therapeutics
08:30 - 10:00
CMC Considerations (including testing) for Pediatric Treatments & Case Study (Global Regulatory Perspectives)

See presentation details and speaker bios 

 

 

Rebecca Lim, PhD (Moderator)
Associate Professor, Obstetrics & Gynaecology, Monash University, Australia
Rebecca Lim, PhD (Moderator)
Associate Professor, Obstetrics & Gynaecology, Monash University, Australia
Ieva Ozolins, MD
Medical Advisor, TGA, Australia
Ieva Ozolins, MD
Medical Advisor, TGA, Australia
Yoshiaki Maruyama, PhD
Review Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshiaki Maruyama, PhD
Review Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mo Heidaran, PhD
VP Technical, PAREXEL, USA
Mo Heidaran, PhD
VP Technical, PAREXEL, USA
08:30 - 10:00
Cord Blood Expansion (Cord Blood Series)
Cord Blood Expansion (Cord Blood Series) image
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Cord Blood Expansion (Cord Blood Series) image
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Cord Blood Expansion (Cord Blood Series) image
Colleen Delaney, MD
Founder and Chief Scientific Officer, Nohla Therapeutics
Cord Blood Expansion (Cord Blood Series) image
Colleen Delaney, MD
Founder and Chief Scientific Officer, Nohla Therapeutics
Cord Blood Expansion (Cord Blood Series) image
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Cord Blood Expansion (Cord Blood Series) image
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
10:00 - 10:15
Coffee Break
10:15 - 11:15
Risk Assessment for Administration of Non-conforming Products & Case Study (Global Regulatory Perspectives)

See presentation details and speaker bios 

 

 

David Ritchie, Prof., MD, PhD (Moderator)
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
David Ritchie, Prof., MD, PhD (Moderator)
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
Steven Oh, PhD
Deputy Director, Office of Tissues and Advanced Therapies, FDA, USA
Steven Oh, PhD
Deputy Director, Office of Tissues and Advanced Therapies, FDA, USA
Stephan Kadauke, MD, PhD
Assistant Director, Cell and Gene Therapy Lab, CHOP, USA
Stephan Kadauke, MD, PhD
Assistant Director, Cell and Gene Therapy Lab, CHOP, USA
10:15 - 11:45
Specialized Cell Processing (Cell Processing Track)

See presentation details and speaker bios 

 

 

Specialized Cell Processing (Cell Processing Track) image
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Specialized Cell Processing (Cell Processing Track) image
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Specialized Cell Processing (Cell Processing Track) image
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Specialized Cell Processing (Cell Processing Track) image
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Specialized Cell Processing (Cell Processing Track) image
Leela L. Paris, PhD
Global Product Manager, Cook Regentec, United States
Specialized Cell Processing (Cell Processing Track) image
Leela L. Paris, PhD
Global Product Manager, Cook Regentec, United States
Specialized Cell Processing (Cell Processing Track) image
Frances Harding, PhD
Cell Therapies Specialist/Project Lead, Cell Therapies Pty. Ltd
Specialized Cell Processing (Cell Processing Track) image
Frances Harding, PhD
Cell Therapies Specialist/Project Lead, Cell Therapies Pty. Ltd
Specialized Cell Processing (Cell Processing Track) image
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
Specialized Cell Processing (Cell Processing Track) image
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
10:15 - 11:45
Performing Risk Assessment, What Now? (ISCT-FACT Quality Bootcamp)

See presentation details and speaker bios 

 

 

10:15 - 11:45
Cord Blood for Neurological Disorders (Cord Blood Series)
Cord Blood for Neurological Disorders (Cord Blood Series) image
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Cord Blood for Neurological Disorders (Cord Blood Series) image
Joanne Kurtzberg, MD
Director, Carolinas Cord Blood Bank Duke University Medical Center, United States
Cord Blood for Neurological Disorders (Cord Blood Series) image
Won Soon Park MD, PhD
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
Cord Blood for Neurological Disorders (Cord Blood Series) image
Won Soon Park MD, PhD
Professor of Pediatrics, Samsung medical Center, Sungkyunkwan University, School of Medicine
Cord Blood for Neurological Disorders (Cord Blood Series) image
MinYoung Kim MD, PhD
Professor, CHA University
Cord Blood for Neurological Disorders (Cord Blood Series) image
MinYoung Kim MD, PhD
Professor, CHA University
10:15 - 11:45
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop)

See presentation details and speaker bios 

 

 

Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Pawan Kumar Gupta, MBBS, MD, DNB, PhD
Senior Director Medical Services, Stempeutics Research
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Pawan Kumar Gupta, MBBS, MD, DNB, PhD
Senior Director Medical Services, Stempeutics Research
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Andy Peng Xiang, PhD
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Clinical Trials Part II: Asia Pacific Spotlight (MSC Workshop) image
Andy Peng Xiang, PhD
Professor, Center for stem cell biology and tissue engineering, Sun Yat-sen University
Fusheng Wang, MD, PhD,
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
Fusheng Wang, MD, PhD,
Director of both Treatment and Research Center for Infectious Diseases and The Institute of Translational Hepatology, Beijing 302 Hospital
10:15 - 11:45
Stem Cell Crystal Ball – Navigating Contemporary Practice and Imagining the Future
Stem Cell Crystal Ball – Navigating Contemporary Practice and Imagining the Future image
Megan Munsie, PhD
Deputy Director, Centre for Stem Cell Systems, University of Melbourne, Australia
Stem Cell Crystal Ball – Navigating Contemporary Practice and Imagining the Future image
Megan Munsie, PhD
Deputy Director, Centre for Stem Cell Systems, University of Melbourne, Australia
Ashley Ng, MBBS, FRACP, FRACP Haem
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Ashley Ng, MBBS, FRACP, FRACP Haem
Royal Melbourne Hospital and the Walter and Eliza Hall Institute of Medical Research
Rosa McCarty, PhD, GCUT
University of Melbourne
Rosa McCarty, PhD, GCUT
University of Melbourne
11:45 - 13:00
Lunch
11:45 - 01:00
Experimental Rigor in Phenotyping and Functional Testing by Flow Cytometry (Industry Luncheon Hosted By Beckman Coulter) (Cell Processing Track)

See presentation details and speaker bios 

 

 

11:45 - 01:00
Next Generation MSC Technologies (Industry Luncheon Hosted By RoosterBio Inc.)

See presentation details and speaker bios 

 

 

12:45 - 14:30
Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives)

See presentation details and speaker bios 

 

 

Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives) image
Dominic Wall, PhD (Moderator)
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives) image
Dominic Wall, PhD (Moderator)
Director of Pathology Operations, Peter MacCallum Cancer Center, Australia
I-Ning Tang, MD
Section Chief of Regulatory Science, Taiwan Center for Drug Evaluation, Taiwan
I-Ning Tang, MD
Section Chief of Regulatory Science, Taiwan Center for Drug Evaluation, Taiwan
Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives) image
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Clinical Strategies for Treatment of Pediatric Diseases & Case Study (Global Regulatory Perspectives) image
Jaap Boelens, MD, PhD
Chief: Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering, USA
Rachel Witten, MD
Lead Medical Officer, FDA, USA
Rachel Witten, MD
Lead Medical Officer, FDA, USA
13:00 - 14:30
Cord Blood Cellular Therapy (Cord Blood Series)
Cord Blood Cellular Therapy (Cord Blood Series) image
Catherine Bollard, MD
Professor, Children's National Medical Center & George Washington University, USA
Cord Blood Cellular Therapy (Cord Blood Series) image
Catherine Bollard, MD
Professor, Children's National Medical Center & George Washington University, USA
Katy Rezvani, MBBS, PhD
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Katy Rezvani, MBBS, PhD
Professor of Medicine, University of Texas MD Anderson Cancer Research Center
Cord Blood Cellular Therapy (Cord Blood Series) image
Yufang Shi, PhD
Director, Institutes for Translational Medicine
Cord Blood Cellular Therapy (Cord Blood Series) image
Yufang Shi, PhD
Director, Institutes for Translational Medicine
13:00 - 14:30
Process Validation 101 (ISCT-FACT Quality Bootcamp)

See presentation details and speaker bios 

 

 

Process Validation 101 (ISCT-FACT Quality Bootcamp) image
Annette Trickett, PhD
Director BMT Laboratory,Sydney Children’s Hospital and Prince of Wales Hospital, Australia
Process Validation 101 (ISCT-FACT Quality Bootcamp) image
Annette Trickett, PhD
Director BMT Laboratory,Sydney Children’s Hospital and Prince of Wales Hospital, Australia
13:00 - 14:30
ISCT Chief Scientific Officer Emerging Technologies Showcase
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Daniel J. Weiss
Professor of Medicine, University of Vermont College of Medicine
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Daniel J. Weiss
Professor of Medicine, University of Vermont College of Medicine
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Stan Gronthos, PhD
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Stan Gronthos, PhD
Professor Stem Cell Biology and Regenerative Medicine, The University of Adelaide
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Masayo Takahashi, MD, PhD
Project Leader, Retinal Renegeration Laboratory, RIKEN Center, Japan
ISCT Chief Scientific Officer Emerging Technologies Showcase image
Masayo Takahashi, MD, PhD
Project Leader, Retinal Renegeration Laboratory, RIKEN Center, Japan
13:00 - 14:30
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track)

See presentation details and speaker bios 

 

 

Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Ruud Hulspas, PhD
Vice President Scientific Affairs, Cellular Therapies Bioconsulting, LLC
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Paul Wallace, PhD
Professor of Oncology and Director, Departmet of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Paul Neeson, PhD
Associate Professor, University of Melbourne; Peter MacCallum Cancer Centre, Australia
Product Testing and Characterization by Flow Cytometry – A Joint Session with the International Society for Advancement of Cytometry (Cell Processing Track) image
Paul Neeson, PhD
Associate Professor, University of Melbourne; Peter MacCallum Cancer Centre, Australia
13:00 - 14:30
MSC Regulatory Landscape (MSC Workshop)

See presentation details and speaker bios 

 

 

MSC Regulatory Landscape (MSC Workshop) image
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
MSC Regulatory Landscape (MSC Workshop) image
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
MSC Regulatory Landscape (MSC Workshop) image
Yoji Sato, PhD
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
MSC Regulatory Landscape (MSC Workshop) image
Yoji Sato, PhD
Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
MSC Regulatory Landscape (MSC Workshop) image
Tony Manderson, PhD
Head, Cell & Tissue Therapies Unit, TGA
MSC Regulatory Landscape (MSC Workshop) image
Tony Manderson, PhD
Head, Cell & Tissue Therapies Unit, TGA
14:30 - 14:45
Coffee Break
14:45 - 16:15
Doing Business in Korea
So Ra Park, MD, PhD
Secretary General, Council for Advanced Regenerative Medicine (CARM)
So Ra Park, MD, PhD
Secretary General, Council for Advanced Regenerative Medicine (CARM)
Doing Business in Korea image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Doing Business in Korea image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
In-Taek Lim
Director General, Bureau of Health Industry, MoHW
In-Taek Lim
Director General, Bureau of Health Industry, MoHW
Sung hyun Choi
Project Leader (PL), Daewoong Co., Ltd
Sung hyun Choi
Project Leader (PL), Daewoong Co., Ltd
Nam Ho Kim
Researcher, Biosolution co., Ltd.
Nam Ho Kim
Researcher, Biosolution co., Ltd.
Donghoon Oh
Chief Scientific Officer, STEMLAB, Inc.
Donghoon Oh
Chief Scientific Officer, STEMLAB, Inc.
San U. Song
Founder and Chief Scientific Officer, SCM Lifescience Co. Ltd
San U. Song
Founder and Chief Scientific Officer, SCM Lifescience Co. Ltd
Jooyoun Lee
President of R&D Center, Xcell Therapeutics
Jooyoun Lee
President of R&D Center, Xcell Therapeutics
Jong Seong Ahn
Research Center Director, Green Cross Cell corp.
Jong Seong Ahn
Research Center Director, Green Cross Cell corp.
Gunsoo Kim
Chief Executive Officer, Curocell Inc.
Gunsoo Kim
Chief Executive Officer, Curocell Inc.
14:45 - 16:15
Cord Blood Derived MSCs, Exosomes, and Regenerative Medicine (Cord Blood Series)
Cord Blood Derived MSCs, Exosomes, and Regenerative Medicine (Cord Blood Series) image
Elizabeth J. Shpall, MD
Professor of Medicine, MD Anderson Cancer Center
Cord Blood Derived MSCs, Exosomes, and Regenerative Medicine (Cord Blood Series) image
Elizabeth J. Shpall, MD
Professor of Medicine, MD Anderson Cancer Center
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Willem E. Fibbe, MD, PhD
Professor, Leiden University Medical Center
Helen E. Heslop, MD
Professor of Medicine and Pediatrics, Baylor College of Medicine
Helen E. Heslop, MD
Professor of Medicine and Pediatrics, Baylor College of Medicine
14:45 - 16:15
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop)

See presentation details and speaker bios 

 

 

Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Donald Phinney, PhD
Professor, The Scripps Research Institute, Scripps Florida, USA
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Donald Phinney, PhD
Professor, The Scripps Research Institute, Scripps Florida, USA
Luis Ortiz, PhD
Professor, University of Pittsburgh
Luis Ortiz, PhD
Professor, University of Pittsburgh
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Songtao Shi, DDS, MS, PhD
Professor and Chair, Department of Anatomy & Cell Biology, University of Pennsylvania
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Yufang Shi, PhD
Director, Institutes for Translational Medicine
Clinical Trials Part III: Characterization and Future Perspectives (MSC Workshop) image
Yufang Shi, PhD
Director, Institutes for Translational Medicine
14:45 - 16:15
Evaluating and Reporting Audit Results (ISCT-FACT Quality Bootcamp)

See presentation details and speaker bios 

 

 

14:45 - 15:45
Regulatory Convergence: Where we are and what we are up to? (Global Regulatory Perspectives)

See presentation details and speaker bios 

 

 

Karen Nichols, Esq.
VP, Magenta Therapeutics
Karen Nichols, Esq.
VP, Magenta Therapeutics
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Srinivasan Kellathur, PhD
Head, Advanced Therapy Products Unit, Health Sciences Authority, Singapore
Srinivasan Kellathur, PhD
Head, Advanced Therapy Products Unit, Health Sciences Authority, Singapore
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
14:45 - 16:15
Post-Infusion to Commercialization (Cell Processing Track)

See presentation details and speaker bios 

 

 

Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Mara Neal, SH(ASCP)MT, MS, MBA
Director, Cook Regentec
Post-Infusion to Commercialization (Cell Processing Track) image
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Post-Infusion to Commercialization (Cell Processing Track) image
Vicki Antonenas, BSc, MSc
Scientific Director, Westmead Hospital
Post-Infusion to Commercialization (Cell Processing Track) image
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Post-Infusion to Commercialization (Cell Processing Track) image
Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA
Haematologist and Blood and Marrow Transplant Physician, Westmead Hospital, Australia
Post-Infusion to Commercialization (Cell Processing Track) image
Virginia Litwin, PhD
Vice President, Immunology, Caprion Biosciences Inc., Canada
Post-Infusion to Commercialization (Cell Processing Track) image
Virginia Litwin, PhD
Vice President, Immunology, Caprion Biosciences Inc., Canada
Post-Infusion to Commercialization (Cell Processing Track) image
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
Post-Infusion to Commercialization (Cell Processing Track) image
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, USA
16:30 - 18:30
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec)

See Program Details

Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Amit Chandra, PhD
Innovation Supervisor Cell Therapy, Yposkesi SAS, France
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Amit Chandra, PhD
Innovation Supervisor Cell Therapy, Yposkesi SAS, France
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Lin Yang, Prof., PhD
Founder, Chairman, and CSO, PersonGen BioTherapeutics (Suzhou) Co., Ltd., China
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Lin Yang, Prof., PhD
Founder, Chairman, and CSO, PersonGen BioTherapeutics (Suzhou) Co., Ltd., China
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Marcos de Lima, Prof., MD
Director, Stem Cell Transplant and Hematologic Malignancies, University Hospitals Cleveland Medical Center, USA
Cutting-Edge Manufacturing Solutions for Advanced Cell Therapies (Corporate Symposium Hosted By Miltenyi Biotec) image
Marcos de Lima, Prof., MD
Director, Stem Cell Transplant and Hematologic Malignancies, University Hospitals Cleveland Medical Center, USA
19:00 - 21:30
ISCT 2019 President’s Welcome Address and Exhibit Open House Reception
19:45 - 20:00
Establishing the CCRM Model in Australia and Beyond: Opportunities and Challenges (ISCT Global Showcase Opening Address Hosted by CCRM)

See program details

Establishing the CCRM Model in Australia and Beyond: Opportunities and Challenges (ISCT Global Showcase Opening Address Hosted by CCRM) image
Michael May, PhD
President and CEO, CCRM, Canada
Establishing the CCRM Model in Australia and Beyond: Opportunities and Challenges (ISCT Global Showcase Opening Address Hosted by CCRM) image
Michael May, PhD
President and CEO, CCRM, Canada
Thursday
2019-05-30
Plenary Hall
Room 212
Room 220
Room 213
Room 219
Offsite
Poster Hall
Exhibit Hall
Room 217
ISCT Global Showcase Lounge
07:30 - 08:30
Overcoming Challenges in Cell Therapy Manufacturing (Corporate Breakfast Tutorial Hosted By Thermo Fisher Scientific)
Randy Schweickart
Director of Engineering, Juno Therapeutics, Inc
Randy Schweickart
Director of Engineering, Juno Therapeutics, Inc
Tia Hexom
Field Applications Scientist, Thermo Fisher Scientific
Tia Hexom
Field Applications Scientist, Thermo Fisher Scientific
07:30 - 08:30
Commercial, Manufacturing and Clinical Aspects of a Multinational Rare Disease Gene Therapy Trial (Corporate Breakfast Tutorial Hosted by Cell Therapies Pty Ltd)

See program details

Nathan Smith
Project Portfolio Manager, Cell Therapies Pty Ltd, Australia
Nathan Smith
Project Portfolio Manager, Cell Therapies Pty Ltd, Australia
Geoff Mackay
Chief Executive Officer, AvroBio, USA
Geoff Mackay
Chief Executive Officer, AvroBio, USA
Alexandra Rizzitelli, PhD
Cell Therapy Specialist, Cell Therapies Pty Ltd, Australia
Alexandra Rizzitelli, PhD
Cell Therapy Specialist, Cell Therapies Pty Ltd, Australia
David Ritchie, Prof., MD, PhD
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
David Ritchie, Prof., MD, PhD
Haematologist & Head of Allogeneic Stem Cell Transplantation, The Royal Melbourne Hospital, Australia
07:30 - 08:30
Hot Topic Session 1 – Bioengineering of the GI Tract

See presentation details and speaker bios

Hot Topic Session 1 – Bioengineering of the GI Tract image
Rachele Ciccocioppo, MD
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Hot Topic Session 1 – Bioengineering of the GI Tract image
Rachele Ciccocioppo, MD
Associate Professor in Gastroenterology, University of Verona School of Medicine, Italy
Hot Topic Session 1 – Bioengineering of the GI Tract image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Hot Topic Session 1 – Bioengineering of the GI Tract image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Hot Topic Session 1 – Bioengineering of the GI Tract image
Giuseppe Orlando, MD, PhD
Assistant Professor, Wake Forest University Baptist Medical Center, USA
Hot Topic Session 1 – Bioengineering of the GI Tract image
Giuseppe Orlando, MD, PhD
Assistant Professor, Wake Forest University Baptist Medical Center, USA
07:30 - 08:30
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee

See presentation details and speaker bios

Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
George Muschler, MD
Orthopaedic Surgeon, Cleveland Clinic, United States
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
George Muschler, MD
Orthopaedic Surgeon, Cleveland Clinic, United States
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Nakamura Norimasa, MD, PhD
Professor, Osaka Health Science University, Japan
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Nakamura Norimasa, MD, PhD
Professor, Osaka Health Science University, Japan
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Danièle Noël, PhD
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Danièle Noël, PhD
Research Director, Inserm Institute for Regenerative Medicine and Biotherapies, France
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Constance Chu, MD
Professor of Orthopaedic Surgery, Stanford University School of Medicine, USA
Hot Topic Session 2 – Getting to the Truth – Designing Studies and Clinical Network for Objective Evaluation of Cellular Therapies for Osteoarthritis of the Knee image
Constance Chu, MD
Professor of Orthopaedic Surgery, Stanford University School of Medicine, USA
08:30 - 09:00
Opening Remarks, 2019 Cell Therapy Training Course Scholars Announcement, Presentation of 2019 Career Achievement Award in Cellular Therapy to John Barrett, MD, FRCP, FRCPath
09:00 - 10:30
Presidential Plenary: CAR-Ts Beyond B Cells

See presentation details and speaker bios 

 

 

Presidential Plenary: CAR-Ts Beyond B Cells image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Presidential Plenary: CAR-Ts Beyond B Cells image
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
Professor & Head of Gene and Stem Cell Therapy Program, University of Sydney, Australia
Presidential Plenary: CAR-Ts Beyond B Cells image
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Presidential Plenary: CAR-Ts Beyond B Cells image
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Presidential Plenary: CAR-Ts Beyond B Cells image
Weidong Han, MD, PhD
Professor, Chinese PLA General Hospital, China
Presidential Plenary: CAR-Ts Beyond B Cells image
Weidong Han, MD, PhD
Professor, Chinese PLA General Hospital, China
Presidential Plenary: CAR-Ts Beyond B Cells image
Franco Locatelli, MD, PhD
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
Presidential Plenary: CAR-Ts Beyond B Cells image
Franco Locatelli, MD, PhD
Full Professor of Pediatrics, University of Pavia/IRCCS Ospedale Pediatrico Bambino Gesù, Italy
10:30 - 11:00
Coffee Break
10:30 - 10:45
Solutions That Enable Efficiencies in cGMP Manufacturing (Global Showcase Presentation Hosted By GE Healthcare)

See program details

Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
10:45 - 11:00
Engineered for Life – BIOSTAT® RM TX with FLEXSAFE® RM TX for Culturing Consistent Quality Cellular Products (Global Showcase Presentation Hosted By Sartorius Stedim Biotech)

See program details

Ruth McDermott
Platform Manager Regenerative Medicine, Sartorius Stedim Biotech, UK
Ruth McDermott
Platform Manager Regenerative Medicine, Sartorius Stedim Biotech, UK
11:00 - 12:15
Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies

See presentation details and speaker bios 

 

 

Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies image
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies image
Sowmya Viswanathan, PhD
Affiliate Scientist, Cell Therapy Program, University Health Network, Canada
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Judith Arcidiacono, MS
Regulatory Scientist, FDA, USA
Brian Hawkins, PhD
Chief Technology Officer, Pluristyx, Inc., USA
Brian Hawkins, PhD
Chief Technology Officer, Pluristyx, Inc., USA
Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies image
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
Quality and Operations Track Session 1 – Emerging Standards in Cell & Gene Therapies image
Paul Eldridge, PhD
Director, Cell GMP Facility, University of North Carolina Chapel-Hill, United States
11:00 - 12:15
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy

See presentation details and speaker bios 

Megan Cornelison, MS, PA-C
MD Anderson Cancer Center
Megan Cornelison, MS, PA-C
MD Anderson Cancer Center
Tobi Fisher, MPAS, PA-C
MD Anderson Cancer Center
Tobi Fisher, MPAS, PA-C
MD Anderson Cancer Center
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
Juliet Barker, MBBS, FRACP
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
Juliet Barker, MBBS, FRACP
Attending Physician, Memorial Sloan Kettering Cancer Center, New York, USA
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
Ngaire Elwood, PhD
Director, BMDI Cord Blood Bank, Australia
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
Ngaire Elwood, PhD
Director, BMDI Cord Blood Bank, Australia
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
David DiGiusto, PhD
Chief Technical Officer, Semma Therapeutics, United States
Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy image
David DiGiusto, PhD
Chief Technical Officer, Semma Therapeutics, United States
11:00 - 12:15
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine

See presentation details and speaker bios 

Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Shoji Takeuchi, PhD
Professor, Graduate School of Information Science and Technology, University of Tokyo, Japan
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Shoji Takeuchi, PhD
Professor, Graduate School of Information Science and Technology, University of Tokyo, Japan
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Jessica Frith, PhD
Monash University, Australia
Plenary 2 Satellite Session – Enabling Technologies in Regenerative Medicine image
Jessica Frith, PhD
Monash University, Australia
11:00 - 12:15
Regulatory Spotlight – Clinical Site Cell Supply for Commercial CAR-T Products – How to Integrate Regional Rules and Policies into Global Networks

See presentation details and speaker bios 

 

Simon Harrison, MBBS, PhD
Director of Clinical Aphaeresis, Peter MacCallum Cancer Centre, Australia
Simon Harrison, MBBS, PhD
Director of Clinical Aphaeresis, Peter MacCallum Cancer Centre, Australia
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
Francesco Cicirello, PharmD (GPhC, FOPH), MSc
Inspector, Therapeutic Goods Administration
Bryan Silvey
Kite, A Gilead Company
Bryan Silvey
Kite, A Gilead Company
Peter Holman, MS
Novartis, United States
Peter Holman, MS
Novartis, United States
11:00 - 12:15
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I

See presentation details and speaker bios 

Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
Saar Gill, MD, PhD
Assistant Professor, University of Pennsylvania, Philadelphia, USA
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
David Bishop, MBBS
Haematologist, Westmead Institute for Medical Research, Australia
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
David Bishop, MBBS
Haematologist, Westmead Institute for Medical Research, Australia
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
Plenary 1 Satellite Session – Immunotherapy Oral Abstract Presentations I image
Patrick Hanley, PhD
Director, GMP for Immunotherapy Children's National Medical Center, USA
11:00 - 12:15
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale

See session description and presentation details

Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Simon Ellison, MBA
Service Director, Cell and Gene Therapy, World Courier, United Kingdom
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Simon Ellison, MBA
Service Director, Cell and Gene Therapy, World Courier, United Kingdom
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Heidi Hagen, MS, MBA
Co-Founder & Chief Strategy Officer Vineti, Inc, USA
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Heidi Hagen, MS, MBA
Co-Founder & Chief Strategy Officer Vineti, Inc, USA
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Kilian Kelly, PhD
Vice President, Product Development, Cynata Therapeutics, Australia
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Kilian Kelly, PhD
Vice President, Product Development, Cynata Therapeutics, Australia
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Andrew McDonald
Director, Australia & New Zealand, World Courier, Australia
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Andrew McDonald
Director, Australia & New Zealand, World Courier, Australia
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
Strategies for Commercialization Track Session 1 – Think Big and Think Early to Prevent Failure at Commercial Scale image
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
12:15 - 13:45
Lunch with Exhibits
12:30 - 13:30
Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted by GE Healthcare)

See program details

Phil Vanek, PhD
GM, Growth Strategy, GEHC Cell and Gene Therapy, USA
Phil Vanek, PhD
GM, Growth Strategy, GEHC Cell and Gene Therapy, USA
Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted by GE Healthcare) image
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted by GE Healthcare) image
Robin Ng, PhD
Strategy Lead, Technology & Manufacturing, Cellular Biomedicine Group, China
Rohin Iyer, PhD
Development Manager, Cell and Gene Therapy, GEHC/FASTTrak@CCRM
Rohin Iyer, PhD
Development Manager, Cell and Gene Therapy, GEHC/FASTTrak@CCRM
Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
Greg Crescenzi
Enterprise Solutions Leader, GEHC Cell and Gene Therapy
12:30 - 12:45
Beyond Blood – Supporting Cell Therapies From the Bottom Up (Global Showcase Presentation Hosted By Australian Red Cross Blood Service)

See program details

Shane Winzar
Australian Red Cross Blood Service, Australia
Shane Winzar
Australian Red Cross Blood Service, Australia
Augustin Raj
Australian Red Cross Blood Service, Australia
Augustin Raj
Australian Red Cross Blood Service, Australia
12:45 - 13:00
Regeneus’ Novel Allogenic Stem Cell Platforms for Musculoskeletal and Neuropathic Pain Disorders (Global Showcase Presentation Hosted By Regeneus Ltd)

See program details 

Charlotte Morgan, PhD
Head of R&D, Regeneus, Australia
Charlotte Morgan, PhD
Head of R&D, Regeneus, Australia
13:00 - 13:15
HPL Pathogen Reduction Treatment and Risk Assessment (Global Showcase Presentation Hosted By AventaCell Biomedical)

See program details

HPL Pathogen Reduction Treatment and Risk Assessment (Global Showcase Presentation Hosted By AventaCell Biomedical) image
Bill Milligan
SVP Corporate Development & Business Development, Steminent Biotherapeutics, Canada
HPL Pathogen Reduction Treatment and Risk Assessment (Global Showcase Presentation Hosted By AventaCell Biomedical) image
Bill Milligan
SVP Corporate Development & Business Development, Steminent Biotherapeutics, Canada
13:15 - 13:30
Fast Forward to hMSC Manufacturing: A Novel, Xeno-Free Medium Supporting Planar Suspension Formats for Easy Scale-Up (Global Showcase Presentation Hosted By Merck)

See program details

Kathleen Ongena, PhD
Head of Biomaterials and Assays, Cell Therapy Bioprocessing, Merck, United States
Kathleen Ongena, PhD
Head of Biomaterials and Assays, Cell Therapy Bioprocessing, Merck, United States
13:45 - 15:15
Plenary Session 2 – Complex Cellular Structures: Realising The Regenerative Potential of Cells

See presentation details and speaker bios. 

Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Oscar K. Lee, MD, PhD
Chair Professor, National Yang-Ming University, Taiwan
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Janet Macpherson, PhD
Product Sales Specialist, Cell & Gene Therapy, GE Healthcare, Australia
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Janet Macpherson, PhD
Product Sales Specialist, Cell & Gene Therapy, GE Healthcare, Australia
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Melissa Little, PhD
Theme Director of Cell Biology, Murdoch Children's Research Institute, Australia
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Yoshiki Sawa, MD, PhD
Professor, Osaka University, Japan
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Yoshiki Sawa, MD, PhD
Professor, Osaka University, Japan
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
Plenary Session 2 –  Complex Cellular Structures: Realising The Regenerative Potential of Cells image
Tracy Grikscheit, MD
Attending Physician, Children's Hospital of Los Angeles, United States
15:15 - 15:30
Industrializing Cell and Gene Therapy: Upstream Technologies (Global Showcase Presentation Hosted By Pall Biotech)

See program details

Seunghoon Choe, BSc., Meng
Bioprocess Applications Specialist, Pall Biotech, South Korea
Seunghoon Choe, BSc., Meng
Bioprocess Applications Specialist, Pall Biotech, South Korea
15:15 - 15:45
Coffee Break
15:30 - 15:45
A Novel, Single-Use Bioreactor System for Expansion of Human Mesenchymal Stem/Stromal Cell (Global Showcase Presentation Hosted by Pall Biotech)
Kaitlynn Bayne
Associate Scientist, Pall Biotech, United States
Kaitlynn Bayne
Associate Scientist, Pall Biotech, United States
15:45 - 17:00
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer

See presentation details and speaker bios 

Megan Cornelison, MS, PA-C
MD Anderson Cancer Center
Megan Cornelison, MS, PA-C
MD Anderson Cancer Center
Tobi Fisher, MPAS, PA-C
MD Anderson Cancer Center
Tobi Fisher, MPAS, PA-C
MD Anderson Cancer Center
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer image
Michael Brown, MBBS, PhD
Professor, Head, Translational Oncology Laboratory, University of South Australia, Australia
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer image
Michael Brown, MBBS, PhD
Professor, Head, Translational Oncology Laboratory, University of South Australia, Australia
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer image
Cameron Turtle, MBBS, PhD
Attending Physician, Fred Hutchinson Cancer Research Center, United States
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer image
Cameron Turtle, MBBS, PhD
Attending Physician, Fred Hutchinson Cancer Research Center, United States
Advanced Practice Professionals (APP track) Session 2 – Novel Therapies for Treating Cancer image
Cassian Yee, MD
Professor, MD Anderson Cancer Center, United States